Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Shuko, Saku"'
Autor:
Rie Sugihara, Hidetaka Watanabe, Shuntaro Matsushima, Yuriko Katagiri, Shuko Saku, Mina Okabe, Yuko Takao, Nobutaka Iwakuma, Etsuyo Ogo, Fumihiko Fujita, Uhi Toh
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background The primary tumor resection (PTR) of de novo stage IV breast cancer (DnIV BC) is controversial, and previous studies have suggested that the neutrophil-to-lymphocyte ratio (NLR) could be a poor-prognosis factor for BC. We investig
Externí odkaz:
https://doaj.org/article/da888d77f3f348358e3bf2fc77371236
Autor:
Yuko, Takao, Uhi, Toh, Sayaka, Sakurai, Shuko, Saku, Miki, Takenaka, Momoko, Akashi, Rie, Sugihara, Etsuyo, Ogo, Yoshito, Akagi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(8)
Clinical evidence has indicated that, after neo-adjuvant chemotherapy(NAC), sentinel node(SN)identification rates(IR) were lower and false-negative rates(FNR)were higher for patients(pts)with local advanced breast cancer(BC)than for pts with early st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee860581ed8b008a8e48904bc1b5c4e9
https://pubmed.ncbi.nlm.nih.gov/32829360
https://pubmed.ncbi.nlm.nih.gov/32829360
Autor:
Kyogo Itoh, Shigeki Shichijo, Nobutaka Iwakuma, Uhi Toh, Akira Yamada, Yoshito Akagi, Yuko Takao, Shuko Saku, Sayaka Sakurai, Mina Okabe
Publikováno v:
Cancer Science
We undertook an early phase II study of mixed 19‐peptide cancer vaccine monotherapy for 14 advanced metastatic triple‐negative breast cancer (mTNBC) patients refractory to systemic chemotherapy to develop a new type of cancer vaccine. The treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e96b1175cd4acb5ea90957d57470fb
https://pubmed.ncbi.nlm.nih.gov/32495455
https://pubmed.ncbi.nlm.nih.gov/32495455
Autor:
Shigeki Shichijo, Kyogo Itoh, Sayaka Sakurai, Yuko Takao, Uhi Toh, Akira Yamada, Yoshito Akagi, Shuko Saku
Publikováno v:
Experimental and Therapeutic Medicine
The present study assessed plasma IgG in patients with metastatic recurrent breast cancer (mrBC) that is reactive to various T-cell epitope peptides of prostate-related antigens (PRAs), such as prostate-specific antigen, prostate-specific membrane an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bac79528fbc81cc716f73c3fbf8ef9a
https://pubmed.ncbi.nlm.nih.gov/34249152
https://pubmed.ncbi.nlm.nih.gov/34249152
Autor:
Uhi Toh, Akira Yamada, Shigeki Shichijo, Yoshito Akagi, Mina Okabe, Yuko Takao, Kyogo Itoh, Shuko Saku, M Akashi, N Iwakuma
Publikováno v:
Cancer Research. 78:P3-05
Background: We have previously reported the prognostic role of humoral antigen spreading response against prostate-related antigen (PRA) for metastatic recurrent breast cancer (mrBC) patients who received personalized peptide vaccine (PPV) therapy (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12a46d6cdd2b0e1180e8663a9ce0e9ac
https://doi.org/10.1158/1538-7445.sabcs17-p3-05-09
https://doi.org/10.1158/1538-7445.sabcs17-p3-05-09
Autor:
Naoko Seki, Etsuyo Ogo, Akihiko Kawahara, Kyogo Itoh, Uhi Toh, Yuko Kimitsuki, Yoshito Akagi, Nobutaka Iwakuma, Momoko Akashi, Mina Okabe, Shuko Saku
Publikováno v:
Cancer Science
The aim of this research was to investigate the correlation of immunologic factors in the tumor environment of breast cancer, using immunohistological staining to evaluate the expression of programmed death 1/programmed death ligand 1 (PD-1/PD-L1), p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f4e72c2c4c915910173cce73e1d231
https://doi.org/10.1111/cas.13114
https://doi.org/10.1111/cas.13114
Autor:
Uhi Toh, Kyogo Itoh, Sayaka Sakurai, Miki Takenaka, Yuko Takao, Shuko Saku, Shigeki Shichijo, Yoshito Akagi
Publikováno v:
Cancer Research. 80:P5-04
Purpose: Our results from the previous clinical trials using personalized peptide vaccines (PPV) combined conventional chemo-hormonal therapies have confirmed the potential for clinical benefit in patients who had higher IgG antibody and/or CTL respo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daa5662778be4ffb0e3b9a19d639cca3
https://doi.org/10.1158/1538-7445.sabcs19-p5-04-21
https://doi.org/10.1158/1538-7445.sabcs19-p5-04-21
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 24:335-341
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1c790d9ad6e88f05544746a9c62ddb7
https://doi.org/10.3804/jjabcs.24.335
https://doi.org/10.3804/jjabcs.24.335
Autor:
Uhi, Toh, Shuko, Saku, Mina, Okabe, Nobutaka, Iwakuma, Yuko, Kimitsuki, Momoko, Akashi, Etsuyo, Ogo, Akira, Yamada, Shigeki, Shichijo, Kyogo, Itoh, Yoshito, Akagi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 43(10)
Our previous phase II clinical trial showed that therapeutically selected personalized peptide vaccines(PPVs)were effective at boosting anticancer immunity; the immune response after PPV was associated with a clinical outcome as a prognostic factor f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6ee1857267c90716ddb79a8614d9d8d
https://pubmed.ncbi.nlm.nih.gov/27760950
https://pubmed.ncbi.nlm.nih.gov/27760950
Autor:
Shuko Saku, Mina Okabe, Nobutaka Iwakuma, Uhi Toh, Kyogo Itoh, Yoshito Akagi, Momoko Akashi, Etsuyo Ogo
Publikováno v:
Journal of Clinical Oncology. 35:e12072-e12072
e12072 Background: The aim of this study was to investigate the correlation of immunologic factors including the expression of PD-1/PD-L1, PTEN, and the density of TILs, macrophages in the tumor area of breast cancer, using immunohistological stainin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4180000cbcd04079379881e93d3ed3ea
https://doi.org/10.1200/jco.2017.35.15_suppl.e12072
https://doi.org/10.1200/jco.2017.35.15_suppl.e12072